The effect of captopril on impaired wound healing in experimental diabetes

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Zandifar, Ehsan ^a,b   Sohrabi Beheshti, Sajedeh ^a,b,c   Zandifar, Alireza ^a,b   Haghjooy Javanmard, Shaghayegh ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PAYAME NOOR UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; GLUCOSE; NITRIC OXIDE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION; TREATMENT RESPONSE; WOUND FLUID; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 84864929804     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/785247     Document Type: Article

References (36)

1. Greenhalgh D. G., Wound healing and diabetes mellitus Clinics in Plastic Surgery 2003 30 1 37 45 (Pubitemid 36288299)
2. Cosentino F., Lscher T. F., Endothelial dysfunction in diabetes mellitus Journal of Cardiovascular Pharmacology 1998 32 3 S54 S61
3. Blakytny R., Jude E., The molecular biology of chronic wounds and delayed healing in diabetes Diabetic Medicine 2006 23 6 594 608 (Pubitemid 43830059)
4. Lobmann R., Ambrosch A., Schultz G., Waldmann K., Schiweck S., Lehnert H., Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients Diabetologia 2002 45 7 1011 1016 (Pubitemid 34762196)
5. Schffer M. R., Tantry U., Efron P. A., Ahrendt G. M., Thornton F. J., Barbul A., Diabetes-impaired healing and reduced wound nitric oxide synthesis: a possible pathophysiologic correlation Surgery 1997 121 5 513 519 (Pubitemid 27202897)
6. Kalani M., Ostergren J., Brismar K., Jrneskog G., Fagrell B., Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers Diabetes Care 1999 22 1 147 151 (Pubitemid 29028312)
7. Martin A., Komada M. R., Sane D. C., Abnormal angiogenesis in diabetes mellitus Medicinal Research Reviews 2003 23 2 117 145 (Pubitemid 36241095)
8. Chua C. C., Hamdy R. C., Chua B. H. L., Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells Biochimica et Biophysica Acta 1998 1401 2 187 194 (Pubitemid 28129101)
9. Tamarat R., Silvestre J. S., Duriez M., Levy B. I., Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways Laboratory Investigation 2002 82 6 747 756 (Pubitemid 34633824)
10. Office of Laboratory Animal Welfare, Office of Extramural Research, National Institutes of Health, Public Health Service Policy on Human Care and Use of Laboratory Animals, 2002, http://grants1.nih.gov/grants/olaw/references/ phspol.htm
11. Yavuz D., Kkkaya B., Haklar G., Ersz O., Akolu E., Akalin S., Effects of captopril and losartan on lipid peroxidation, protein oxidation and nitric oxide release in diabetic rat kidney Prostaglandins Leukotrienes and Essential Fatty Acids 2003 69 4 223 227 (Pubitemid 37463802)
12. Duarte J., Martinez A., Bermejo A., Vera B., Gmez M. J., Cabo P., Zarzuelo A., Cardiovascular effects of captopril and enalapril in obese Zucker rats European Journal of Pharmacology 1999 365 2-3 225 232 (Pubitemid 29070768)
13. Barro C. D., Romanet J. P., Fdili A., Guillot M., Morel F., Gelatinase concentration in tears of corneal-grafted patients Current Eye Research 1998 17 2 174 182 (Pubitemid 28073783)
14. Muller M., Trocme C., Lardy B., Morel F., Halimi S., Benhamou P. Y., Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing Diabetic Medicine 2008 25 4 419 426 (Pubitemid 351490124)
15. Boykin J. V., Baylis C., Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wound healing: a preliminary study Advances in Skin Wound Care 2007 20 7 382 388
16. Haghjooyjavanmard S., Nematbakhsh M., Monajemi A., Soleimani M., von Willebrand factor, C-reactive protein, nitric oxide, and vascular endothelial growth factor in a dietary reversal model of hypercholesterolemia in rabbit Biomedical Papers of the Medical Faculty of the University Palack, Olomouc, Czechoslovakia 2008 152 1 91 95
17. Maruyama K., Asai J., Ii M., Thorne T., Losordo D. W., D'Amore P. A., Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing American Journal of Pathology 2007 170 4 1178 1191 (Pubitemid 47339326)
18. Javanmard S. H., Nematbakhsh M., Monajemi A., L-Arginine supplementation influenced nitrite but not nitrate and total nitrite in rabbit model of hypercholesterolemia Iranian Biomedical Journal 2008 12 3 179 184
19. Clark R. A. F., Cutaneous tissue repair: basic biologic considerations. I Journal of the American Academy of Dermatology 1985 13 5 701 725 (Pubitemid 16245140)
20. Witte M. B., Thornton F. J., Tantry U., Barbul A., L-arginine supplementation enhances diabetic wound healing: involvement of the nitric oxide synthase and arginase pathways Metabolism 2002 51 10 1269 1273 (Pubitemid 35174147)
21. Kmpfer H., Pfeilschifter J., Frank S., Expression and activity of arginase isoenzymes during normal anddiabetes-impaired skin repair Journal of Investigative Dermatology 2003 121 6 1544 1551 (Pubitemid 38005511)
22. Kichuk M. R., Zhang X., Oz M., Michler R., Kaley G., Nasjletti A., Hintze T. H., Angiotensin-converting enzyme inhibitors promote nitric oxide production in coronary microvessels from failing explanted human hearts American Journal of Cardiology 1997 80 3 137A 142A (Pubitemid 27377487)
23. O'Driscoll G., Green D., Rankin J., Stanton K., Taylor R., Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus The Journal of Clinical Investigation 1997 100 3 678 684 (Pubitemid 27340517)
24. Cheetham C., Collis J., O'Driscoll G., Stanton K., Taylor R., Green D., Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes Journal of the American College of Cardiology 2000 36 5 1461 1466
25. Takemoto M., Egashira K., Usui M., Numaguchi K., Tomita H., Tsutsui H., Shimokawa H., Sueishi K., Takeshita A., Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats The Journal of Clinical Investigation 1997 99 2 278 287 (Pubitemid 27053468)
26. Ghiadoni L., Versari D., Magagna A., Kardasz I., Plantinga Y., Giannarelli C., Taddei S., Salvetti A., Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients Journal of Hypertension 2007 25 2 361 366 (Pubitemid 46071933)
27. Tchaikovski V., Olieslagers S., Bhmer F. D., Waltenberger J., Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes Circulation 2009 120 2 150 159
28. Silvestre J. S., Bergaya S., Tamarat R., Duriez M., Boulanger C. M., Levy B. I., Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B2 receptor pathway Circulation Research 2001 89 8 678 683 (Pubitemid 34627067)
29. Li P., Kondo T., Numaguchi Y., Kobayashi K., Aoki M., Inoue N., Okumura K., Murohara T., Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis Hypertension 2008 51 2 252 258 (Pubitemid 351159936)
30. Gohlke P., Kuwer I., Schnell A., Amann K., Mall G., Unger T., Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats Hypertension 1997 29 1 478 482 (Pubitemid 27074086)
31. Gao L., Yu D. M., Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats Chinese Medical Journal 2008 121 21 2129 2133
32. Dulak J., Jzkowicz A., Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies Antioxidants and Redox Signaling 2003 5 1 123 132 (Pubitemid 36337023)
33. Lin M. I., Sessa W. C., Vascular endothelial growth factor signaling to endothelial nitric oxide synthase: more than a FLeeTing moment Circulation Research 2006 99 7 666 668 (Pubitemid 44498299)
34. Walsh D. A., Hu D. E., Wharton J., Catravas J. D., Blake D. R., Fan T. P. D., Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma British Journal of Pharmacology 1997 120 7 1302 1311 (Pubitemid 27149681)
35. Tamarat R., Silvestre J. S., Kubis N., Benessiano J., Duriez M., DeGasparo M., Henrion D., Levy B. I., Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb Hypertension 2002 39 3 830 835 (Pubitemid 34252885)
36. Silvestre J. S., Kamsu-Kom N., Clergue M., Duriez M., Lévy B. I., Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs Journal of Pharmacology and Experimental Therapeutics 2002 303 3 1038 1043 (Pubitemid 35424387)